Eupraxia Pharmaceuticals Inc. EPRX
EPRX
Eupraxia Pharmaceuticals Inc. MDWD
MediWound Ltd. NAUT
Nautilus Biotechnology, Inc. NTHI
Neonc Technologies Holdings, Inc. OBIO
Orchestra BioMed Holdings, Inc. AARD
Aardvark Therapeutics, Inc. Common Stock SLS
SELLAS Life Sciences Group, Inc. IVA
Inventiva S.A. RNAC
Cartesian Therapeutics, Inc. GNFT
Genfit S.A.
Eupraxia Pharmaceuticals Inc. MDWD
MediWound Ltd. NAUT
Nautilus Biotechnology, Inc. NTHI
Neonc Technologies Holdings, Inc. OBIO
Orchestra BioMed Holdings, Inc. AARD
Aardvark Therapeutics, Inc. Common Stock SLS
SELLAS Life Sciences Group, Inc. IVA
Inventiva S.A. RNAC
Cartesian Therapeutics, Inc. GNFT
Genfit S.A.
Performance
| Periode | EPRX | MDWD | NAUT | NTHI | OBIO | AARD | SLS | IVA | RNAC | GNFT |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 47.41 % | -3.04 % | 174.01 % | 47.48 % | 45.15 % | 13.33 % | 49.04 % | 25.00 % | -26.40 % | 39.11 % |
| YTD | 99.68 % | 4.67 % | 14.79 % | -27.10 % | -19.33 % | -4.33 % | 118.69 % | 96.26 % | -56.53 % | 46.74 % |
| 1Y | 95.92 % | 9.53 % | 7.18 % | -27.10 % | -8.82 % | -4.33 % | 178.24 % | 84.21 % | -56.50 % | 48.28 % |
| 3Y | 111.86 % | 100.85 % | 22.78 % | -27.10 % | -56.47 % | -4.33 % | 15.84 % | -6.67 % | -77.70 % | 55.68 % |
| 5Y | 111.86 % | -29.17 % | -81.95 % | -27.10 % | -63.71 % | -4.33 % | -66.43 % | -65.69 % | -91.82 % | 11.73 % |
| 10Y | 111.86 % | -70.90 % | -81.42 % | -27.10 % | -61.93 % | -4.33 % | -99.99 % | -68.70 % | -98.25 % | -74.65 % |
| From the beginning | 111.86 % | -84.42 % | -81.42 % | -27.10 % | -61.93 % | -4.33 % | -100.00 % | -68.70 % | -98.25 % | -74.65 % |